The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
European Commission has approved tislelizumab in combination with chemotherapy for the first-line treatment of oesophageal squamous…
Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there…
A cancer therapy that prompts the body’s immune defenses against viruses and bacteria to attack…
LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion…
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies…
Specially packaged DNA secreted by tumour cells can trigger an immune response that inhibits the…
The Golgi apparatus modifies, sorts and packages proteins to be sent to their final destinations,…
A series of five papers, published today in The Lancet Oncology by a University of Pittsburgh-led international…
Against the backdrop of an alarming increase in the number of people under 50 being…
The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy…